Instrument number PB 82 of 2011
National Health Act 1953
I, FELICITY McNEILL, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this determination under subsection 99ADB(4) and paragraph 99ADH(1)(aa) of the National Health Act 1953.
Dated 13 December 2011
FELICITY McNEILL
First Assistant Secretary (Acting)
Pharmaceutical Benefits Division
Department of Health and Ageing
Part 1 Preliminary
1 Name of Determination
(1) This Determination is the National Health (Weighted average disclosed price – second transitional disclosure cycle) Determination 2011.
(2) This Determination may also be cited as PB 82 of 2011.
2 Commencement
This Determination commences on the day after it is registered.
3 Revocation
The Determination titled ‘Determination made pursuant to subsections 99ADB(4) and 99ADB(5) of the National Health Act 1953’ made on 22 September 2010 and also cited as PB 85 of 2010 is revoked.
4 Definitions
In this Determination:
Act means the National Health Act 1953.
adjusted approved ex-manufacturer price has the same meaning as in subsection 99ADB(1) of the Act.
adjusted approved price to pharmacists has the same meaning as in subsection 99ADB(1) of the Act.
second transitional disclosure cycle has the same meaning as in Part 2 Transitional, regulation 4, of the National Health (Pharmaceutical Benefits) Amendment Regulations 2010 (No.5) (296/2010).
unadjusted price reduction has the same meaning as in subsection 99ADB(1) of the Act.
weighted average disclosed price has the same meaning as in subsection 99ADB(1) of the Act.
5 Weighted average disclosed price for brands of pharmaceutical items – unadjusted price reduction is at least 10%
For subsection 99ADB(4) of the Act, the weighted average disclosed price specified in column 3 of an item in Schedule 1 is the weighted average disclosed price for the brand of pharmaceutical item specified in column 2 of the same item in Schedule 1.
6 Weighted average disclosed price for brands of pharmaceutical items – unadjusted price reduction is less than 10%
For subsection 99ADB(4) of the Act, the weighted average disclosed price specified in column 3 of an item in Schedule 2 is the weighted average disclosed price for the brand of pharmaceutical item specified in column 2 of the same item in Schedule 2.
7 Adjusted approved ex-manufacturer price for brands of pharmaceutical items – unadjusted price reduction is at least 10%
For paragraph 99ADB(4) of the Act, the adjusted approved ex-manufacturer price for a brand of pharmaceutical item specified in column 2 of Schedule 1 is an amount equal to the amount of the weighted average disclosed price of that brand of pharmaceutical item determined under section 5 of this instrument.
8 Adjusted approved price to pharmacists for brands of pharmaceutical items – unadjusted price reduction is at least 10%
For paragraph 99ADB(4) of the Act, the adjusted approved price to pharmacists specified in column 4 of an item in Schedule 1 is the adjusted approved price to pharmacists for the brand of pharmaceutical item specified in column 2 of the same item in Schedule 1.
9 Reduction Day
For paragraph 99ADH(1)(aa) of the Act, a brand of pharmaceutical item in the second transitional disclosure cycle with a data collection period ending at the end of 30 September 2011 has a reduction day of 1 April 2012.
Schedule 1
Brands of pharmaceutical items – unadjusted price reduction is at least 10%
Column 1 | Column 2 | Column 3 | Column 4 | |||
Item | Brand of Pharmaceutical Item | Weighted average disclosed price | Adjusted approved price to pharmacists | |||
| Listed Drug | Form | Manner of administration | Brand |
|
|
1 | Carvedilol | Tablet 12.5 mg | Oral | APO-Carvedilol | 30.57 | 32.87 |
2 | Carvedilol | Tablet 12.5 mg | Oral | Carvedilol generichealth | 30.57 | 32.87 |
3 | Carvedilol | Tablet 12.5 mg | Oral | Carvedilol Sandoz | 30.57 | 32.87 |
4 | Carvedilol | Tablet 12.5 mg | Oral | Chem mart Carvedilol 12.5 mg | 30.57 | 32.87 |
5 | Carvedilol | Tablet 12.5 mg | Oral | Dicarz | 30.57 | 32.87 |
6 | Carvedilol | Tablet 12.5 mg | Oral | Dilasig 12.5 | 30.57 | 32.87 |
7 | Carvedilol | Tablet 12.5 mg | Oral | Dilatrend 12.5 | 30.57 | 32.87 |
8 | Carvedilol | Tablet 12.5 mg | Oral | GenRx Carvedilol | 30.57 | 32.87 |
9 | Carvedilol | Tablet 12.5 mg | Oral | GN-Carvedilol | 30.57 | 32.87 |
10 | Carvedilol | Tablet 12.5 mg | Oral | Terry White Chemists Carvedilol 12.5 mg | 30.57 | 32.87 |
11 | Carvedilol | Tablet 12.5 mg | Oral | Vedilol 12.5 | 30.57 | 32.87 |
12 | Carvedilol | Tablet 25 mg | Oral | APO-Carvedilol | 38.21 | 41.08 |
13 | Carvedilol | Tablet 25 mg | Oral | Carvedilol generichealth | 38.21 | 41.08 |
14 | Carvedilol | Tablet 25 mg | Oral | Carvedilol Sandoz | 38.21 | 41.08 |
15 | Carvedilol | Tablet 25 mg | Oral | Chem mart Carvedilol 25 mg | 38.21 | 41.08 |
16 | Carvedilol | Tablet 25 mg | Oral | Dicarz | 38.21 | 41.08 |
17 | Carvedilol | Tablet 25 mg | Oral | Dilasig 25 | 38.21 | 41.08 |
18 | Carvedilol | Tablet 25 mg | Oral | Dilatrend 25 | 38.21 | 41.08 |
19 | Carvedilol | Tablet 25 mg | Oral | GenRx Carvedilol | 38.21 | 41.08 |
20 | Carvedilol | Tablet 25 mg | Oral | GN-Carvedilol | 38.21 | 41.08 |
21 | Carvedilol | Tablet 25 mg | Oral | Terry White Chemists Carvedilol 25 mg | 38.21 | 41.08 |
22 | Carvedilol | Tablet 25 mg | Oral | Vedilol 25 | 38.21 | 41.08 |
23 | Carvedilol | Tablet 3.125 mg | Oral | APO-Carvedilol | 5.17 | 5.56 |
24 | Carvedilol | Tablet 3.125 mg | Oral | Chem mart Carvedilol 3.125 mg | 5.17 | 5.56 |
25 | Carvedilol | Tablet 3.125 mg | Oral | Dilasig 3.125 | 5.17 | 5.56 |
26 | Carvedilol | Tablet 3.125 mg | Oral | Dilatrend 3.125 | 5.17 | 5.56 |
27 | Carvedilol | Tablet 3.125 mg | Oral | GenRx Carvedilol | 5.17 | 5.56 |
28 | Carvedilol | Tablet 3.125 mg | Oral | GN-Carvedilol | 5.17 | 5.56 |
29 | Carvedilol | Tablet 3.125 mg | Oral | Kredex | 5.17 | 5.56 |
30 | Carvedilol | Tablet 3.125 mg | Oral | Terry White Chemists Carvedilol 3.125 mg | 5.17 | 5.56 |
31 | Carvedilol | Tablet 3.125 mg | Oral | Vedilol 3.125 | 5.17 | 5.56 |
32 | Carvedilol | Tablet 6.25 mg | Oral | APO-Carvedilol | 24.45 | 26.29 |
33 | Carvedilol | Tablet 6.25 mg | Oral | Carvedilol generichealth | 24.45 | 26.29 |
34 | Carvedilol | Tablet 6.25 mg | Oral | Carvedilol Sandoz | 24.45 | 26.29 |
35 | Carvedilol | Tablet 6.25 mg | Oral | Chem mart Carvedilol 6.25 mg | 24.45 | 26.29 |
36 | Carvedilol | Tablet 6.25 mg | Oral | Dicarz | 24.45 | 26.29 |
37 | Carvedilol | Tablet 6.25 mg | Oral | Dilasig 6.25 | 24.45 | 26.29 |
38 | Carvedilol | Tablet 6.25 mg | Oral | Dilatrend 6.25 | 24.45 | 26.29 |
39 | Carvedilol | Tablet 6.25 mg | Oral | GenRx Carvedilol | 24.45 | 26.29 |
40 | Carvedilol | Tablet 6.25 mg | Oral | GN-Carvedilol | 24.45 | 26.29 |
41 | Carvedilol | Tablet 6.25 mg | Oral | Terry White Chemists Carvedilol 6.25 mg | 24.45 | 26.29 |
42 | Carvedilol | Tablet 6.25 mg | Oral | Vedilol 6.25 | 24.45 | 26.29 |
43 | Clopidogrel | Tablet 75 mg | Oral | Clopidogrel-DRLA | 36.39 | 39.13 |
44 | Clopidogrel | Tablet 75 mg (as besilate) | Oral | Clopidogrel Actavis | 36.39 | 39.13 |
45 | Clopidogrel | Tablet 75 mg (as besilate) | Oral | Clopidogrel-GA | 36.39 | 39.13 |
46 | Clopidogrel | Tablet 75 mg (as besilate) | Oral | Clovix 75 | 36.39 | 39.13 |
47 | Clopidogrel | Tablet 75 mg (as hydrogen sulfate) | Oral | APO-Clopidogrel | 36.39 | 39.13 |
48 | Clopidogrel | Tablet 75 mg (as hydrogen sulfate) | Oral | Chem mart Clopidogrel | 36.39 | 39.13 |
49 | Clopidogrel | Tablet 75 mg (as hydrogen sulfate) | Oral | Clopidogrel RBX | 36.39 | 39.13 |
50 | Clopidogrel | Tablet 75 mg (as hydrogen sulfate) | Oral | Clopidogrel Sandoz | 36.39 | 39.13 |
51 | Clopidogrel | Tablet 75 mg (as hydrogen sulfate) | Oral | Clopidogrel Winthrop | 36.39 | 39.13 |
52 | Clopidogrel | Tablet 75 mg (as hydrogen sulfate) | Oral | Iscover | 36.39 | 39.13 |
53 | Clopidogrel | Tablet 75 mg (as hydrogen sulfate) | Oral | Piax | 36.39 | 39.13 |
54 | Clopidogrel | Tablet 75 mg (as hydrogen sulfate) | Oral | Plavix | 36.39 | 39.13 |
55 | Clopidogrel | Tablet 75 mg (as hydrogen sulfate) | Oral | Terry White Chemists Clopidogrel | 36.39 | 39.13 |
56 | Gemcitabine | Powder for I.V. infusion 1 g (as hydrochloride) | Injection | DBL Gemcitabine for Injection | 60.81 | 65.38 |
57 | Gemcitabine | Powder for I.V. infusion 1 g (as hydrochloride) | Injection | Gemcitabine Actavis | 60.81 | 65.38 |
58 | Gemcitabine | Powder for I.V. infusion 1 g (as hydrochloride) | Injection | Gemcitabine Ebewe | 60.81 | 65.38 |
59 | Gemcitabine | Powder for I.V. infusion 1 g (as hydrochloride) | Injection | Gemcitabine Kabi | 60.81 | 65.38 |
60 | Gemcitabine | Powder for I.V. infusion 1 g (as hydrochloride) | Injection | Gemcitabine Sun | 60.81 | 65.38 |
61 | Gemcitabine | Powder for I.V. infusion 1 g (as hydrochloride) | Injection | Gemcite | 60.81 | 65.38 |
62 | Gemcitabine | Powder for I.V. infusion 1 g (as hydrochloride) | Injection | Gemplan | 60.81 | 65.38 |
63 | Gemcitabine | Powder for I.V. infusion 1 g (as hydrochloride) | Injection | Gemzar | 60.81 | 65.38 |
64 | Gemcitabine | Powder for I.V. infusion 2 g (as hydrochloride) | Injection | DBL Gemcitabine for Injection | 121.90 | 131.07 |
65 | Gemcitabine | Powder for I.V. infusion 2 g (as hydrochloride) | Injection | Gemcitabine Kabi | 121.90 | 131.07 |
66 | Gemcitabine | Powder for I.V. infusion 200 mg (as hydrochloride) | Injection | DBL Gemcitabine for Injection | 12.31 | 13.24 |
67 | Gemcitabine | Powder for I.V. infusion 200 mg (as hydrochloride) | Injection | Gemcitabine Actavis | 12.31 | 13.24 |
68 | Gemcitabine | Powder for I.V. infusion 200 mg (as hydrochloride) | Injection | Gemcitabine Ebewe | 12.31 | 13.24 |
69 | Gemcitabine | Powder for I.V. infusion 200 mg (as hydrochloride) | Injection | Gemcitabine Kabi | 12.31 | 13.24 |
70 | Gemcitabine | Powder for I.V. infusion 200 mg (as hydrochloride) | Injection | Gemcitabine Sun | 12.31 | 13.24 |
71 | Gemcitabine | Powder for I.V. infusion 200 mg (as hydrochloride) | Injection | Gemcite | 12.31 | 13.24 |
72 | Gemcitabine | Powder for I.V. infusion 200 mg (as hydrochloride) | Injection | Gemplan | 12.31 | 13.24 |
73 | Gemcitabine | Powder for I.V. infusion 200 mg (as hydrochloride) | Injection | Gemzar | 12.31 | 13.24 |
74 | Gemcitabine | Solution concentrate for I.V. infusion 1000 mg (as hydrochloride) in 100 mL | Injection | Gemcitabine Ebewe | 60.81 | 65.38 |
75 | Gemcitabine | Solution concentrate for I.V. infusion 200 mg (as hydrochloride) in 20 mL | Injection | Gemcitabine Ebewe | 12.31 | 13.24 |
76 | Gemcitabine | Solution concentrate for I.V. infusion 500 mg (as hydrochloride) in 50 mL | Injection | Gemcitabine Ebewe | 30.41 | 32.70 |
77 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL | Injection | Camptosar | 37.95 | 40.80 |
78 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL | Injection | Hospira Pty Limited | 37.95 | 40.80 |
79 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL | Injection | Irinotecan Actavis | 37.95 | 40.80 |
80 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL | Injection | Irinotecan Alphapharm | 37.95 | 40.80 |
81 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL | Injection | Irinotecan Ebewe | 37.95 | 40.80 |
82 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL | Injection | Irinotecan Kabi | 37.95 | 40.80 |
83 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL | Injection | Omegapharm Irinotecan | 37.95 | 40.80 |
84 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL | Injection | Tecan | 37.95 | 40.80 |
85 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 300 mg in 15 mL | Injection | Camptosar | 113.74 | 122.29 |
86 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 300 mg in 15 mL | Injection | Irinotecan Ebewe | 113.74 | 122.29 |
87 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 40 mg in 2 mL | Injection | Camptosar | 15.18 | 16.32 |
88 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 40 mg in 2 mL | Injection | Hospira Pty Limited | 15.18 | 16.32 |
89 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 40 mg in 2 mL | Injection | Irinotecan Actavis | 15.18 | 16.32 |
90 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 40 mg in 2 mL | Injection | Irinotecan Alphapharm | 15.18 | 16.32 |
91 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 40 mg in 2 mL | Injection | Irinotecan Ebewe | 15.18 | 16.32 |
92 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 40 mg in 2 mL | Injection | Irinotecan Kabi | 15.18 | 16.32 |
93 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 40 mg in 2 mL | Injection | Omegapharm Irinotecan | 15.18 | 16.32 |
94 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 40 mg in 2 mL | Injection | Tecan | 15.18 | 16.32 |
95 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 500 mg in 25 mL | Injection | Hospira Pty Limited | 194.45 | 209.07 |
96 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 500 mg in 25 mL | Injection | Irinotecan Actavis 500 | 194.45 | 209.07 |
97 | Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 500 mg in 25 mL | Injection | Irinotecan Ebewe | 194.45 | 209.07 |
98 | Vinorelbine | Solution for I.V. infusion 10 mg (as tartrate) in 1 mL | Injection | Hospira Pty Limited | 22.38 | 24.06 |
99 | Vinorelbine | Solution for I.V. infusion 10 mg (as tartrate) in 1 mL | Injection | Navelbine | 22.38 | 24.06 |
100 | Vinorelbine | Solution for I.V. infusion 10 mg (as tartrate) in 1 mL | Injection | Vinorelbine Ebewe | 22.38 | 24.06 |
101 | Vinorelbine | Solution for I.V. infusion 50 mg (as tartrate) in 5 mL | Injection | Hospira Pty Limited | 93.38 | 100.40 |
102 | Vinorelbine | Solution for I.V. infusion 50 mg (as tartrate) in 5 mL | Injection | Navelbine | 93.38 | 100.40 |
103 | Vinorelbine | Solution for I.V. infusion 50 mg (as tartrate) in 5 mL | Injection | Vinorelbine Ebewe | 93.38 | 100.40 |
104 | Vinorelbine | Solution for I.V. infusion 50 mg (as tartrate) in 5 mL | Injection | Vinorelbine Kabi | 93.38 | 100.40 |
Schedule 2
Brands of pharmaceutical items – unadjusted price reduction is less than 10%
Column 1 | Column 2 | Column 3 | |||
Item | Brand of Pharmaceutical Item | Weighted average disclosed price | |||
| Listed Drug | Form | Manner of administration | Brand |
|
1 | Enalapril with Hydrochlorothiazide | Tablet containing enalapril maleate 20 mg with hydrochlorothiazide 6 mg | Oral | Enalapril/HCT Sandoz | 16.50 |
2 | Enalapril with Hydrochlorothiazide | Tablet containing enalapril maleate 20 mg with hydrochlorothiazide 6 mg | Oral | Renitec Plus 20/6 | 16.50 |
3 | Memantine | Tablet containing memantine hydrochloride 10 mg | Oral | APO-Memantine | 79.50 |
4 | Memantine | Tablet containing memantine hydrochloride 10 mg | Oral | Ebixa | 79.50 |
5 | Memantine | Tablet containing memantine hydrochloride 10 mg | Oral | Memanxa | 79.50 |
6 | Memantine | Tablet containing memantine hydrochloride 20 mg | Oral | Ebixa | 79.50 |
Note
1. All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au.